This Boot Barn Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Author: Avi Kapoor | October 28, 2025 06:23am
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Seaport Global analyst Mitch Kummetz downgraded the rating for Boot Barn Holdings Inc (NYSE:BOOT) from Buy to Neutral. Boot Barn shares closed at $202.07 on Monday. See how other analysts view this stock.
Morgan Stanley analyst Manan Gosalia downgraded Cadence Bank (NYSE:CADE) from Overweight to Equal-Weight and cut the price target from $47 to $40. Cadence Bank shares closed at $38.09 on Monday. See how other analysts view this stock.
Bernstein analyst William Pickering downgraded Intellia Therapeutics Inc (NASDAQ:NTLA) from Outperform to Market Perform but raised the price target from $14 to $14.5. Intellia Therapeutics shares closed at $14.79 on Monday. See how other analysts view this stock.
RBC Capital analyst Luca Issi downgraded Intellia Therapeutics (NASDAQ:NTLA) from Outperform to Sector Perform and slashed the price target from $21 to $14. Intellia Therapeutics closed at $14.79 on Monday. See how other analysts view this stock.
Chardan Capital analyst Keay Nakae downgraded Avidity Biosciences Inc (NASDAQ:RNA) from Buy to Neutral and cut the price target from $75 to $72. Avidity Biosciences shares closed at $70.00 on Monday. See how other analysts view this stock.
Considering buying BOOT stock? Here’s what analysts think:
